Related Experiment Videos
Interleukin-3 expression by activated T cells involves an inducible, T-cell-specific factor and an octamer binding
K Davies1, E C TePas, D G Nathan
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115.
Blood
|February 15, 1993
Summary
The study reveals that the Interleukin-3 (IL-3) promoter
Area of Science:
- Immunology
- Molecular Biology
- Gene Regulation
Background:
- Interleukin-3 (IL-3) expression is restricted to activated T and natural killer cells.
- This expression is precisely regulated by lineage-specific and stimulation-dependent mechanisms.
Purpose of the Study:
- To investigate protein binding and functional significance of the ACT-1 region within the IL-3 promoter.
- To understand the molecular mechanisms underlying T-cell-specific IL-3 gene expression.
Main Methods:
- Analysis of protein-DNA interactions at the ACT-1 site.
- Functional assays to determine the necessity of specific binding sites for IL-3 expression.
Main Results:
- The ACT-1 region binds a T-cell-specific inducible factor at its 5' end, crucial for IL-3 expression.
- A ubiquitously expressed factor, identified as Oct-1 or a related octamer-binding protein, binds the 3' end of ACT-1.
- The ACT-1 site shares functional similarities with the ARRE-1 site in the IL-2 promoter.
Conclusions:
- The IL-3 promoter's ACT-1 region involves distinct protein interactions for regulated gene expression.
- Despite sequence differences, IL-3 and IL-2 promoters share regulatory element organization for T-cell specificity.